Načítá se...
Metastatic melanoma: prognostic factors and survival in patients with brain metastases
Brain metastases from malignant melanoma carry a poor prognosis. Novel systemic agents have improved overall survival (OS), but the value of whole-brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) remains uncertain. The melanoma-specific graded prognostic assessment (msGPA) provides usef...
Uloženo v:
| Vydáno v: | J Neurooncol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5700221/ https://ncbi.nlm.nih.gov/pubmed/28819707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-017-2591-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|